4.6 Article

Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2019.12.072

关键词

immunotherapy; lymph node staging; Merkel cell carcinoma; National Cancer Database; radiation; SEER

向作者/读者索取更多资源

The number of metastatic lymph nodes is the key factor affecting survival in patients with Merkel cell carcinoma (MCC). A novel nodal classification system was developed, which showed improved concordance compared with the American Joint Committee on Cancer, Eighth Edition.
Background: Current lymph node (LN) staging for Merkel cell carcinoma (MCC) does not account for the number of metastatic LNs, which is a primary driver of survival in multiple cancers. Objective: To determine the impact of the number of metastatic LNs on survival in MCC. Methods: Patients with MCC undergoing surgery were identified from the National Cancer Database (NCDB). The association between metastatic LN number and survival was modeled with restricted cubic splines. A novel nodal classification system was derived by using recursive partitioning analysis. MCC patients undergoing surgery in the Surveillance, Epidemiology, and End Results (SEER) Program were used as validation cohort. Results: Among 3670 patients in the NCDB, increasing metastatic LN number was associated with decreased survival (P < .001). Mortality risk increased continuously with each additional positive LN when using multivariable, nonlinear modeling. According to a novel staging system derived via recursive partitioning analysis, the hazard ratio for death in multivariable regression compared with patients without LN involvement was 1.24 (P = .049), 2.08 (P < .001), 3.24 (P < .001), and 6.13 (P < .001) for the proposed N1a (1-3 metastatic LNs with microscopic detection), N1b (1-3 metastatic LNs with macroscopic detection), N2 (4-8 metastatic LNs), and N3 (>= 9 metastatic LNs), respectively. This system was validated in the SEER cohort and showed improved concordance compared with the American Joint Committee on Cancer, Eighth Edition. Limitations: Retrospective design. Conclusions: Number of metastatic LNs is the dominant nodal factor driving survival in patients with MCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据